ENHERTU® Granted Priority Review in the U.S. for Patients with Previously Treated HER2 Mutant Metastatic Non-Small Cell Lung Cancer
Based on pivotal DESTINY-Lung01 results showing Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a 54.9% tumor response rate If approved, ENHERTU...

Nico Paz puts Como on Europe’s radar with a brace-less four-goal win, a Tenerife tribute and Premier League bidders sniffing
Allegri’s Napoli Fractures as Porto Claims 4-1 Champions League Romp
Google extends voluntary buyouts to five more countries as AI costs pinch Alphabet
Douvikas hat-trick fuels Como’s record 9-1 demolition of Lens
Guirassy injured as Dortmund host Betis in Champions League 






















